Diabetes, Obesity & Metabolism
Risk of Age-Related Ocular Diseases in Non-Diabetic Adults With Obesity Using Glucagon-Like Peptide 1 Receptor Agonists
Cohort study of 68,536 peopleObesity
Papers on phentermine-topiramate
15 papers
Tuesday, June 9
Friday, March 20
Thursday, March 5
Saturday, December 27
Ophthalmology Retina
Rate of Age-Related Macular Degeneration in Patients Prescribed Glucagon-Like Peptide-1 Receptor Agonists or Other Weight Loss Therapies
Cohort study of 60,336 peopleAge-related macular degeneration
Thursday, November 13
Wednesday, November 12
Monday, November 3
AHA Scientific Sessions 2025 Abstract
Real-World Effectiveness of GLP-1 Receptor Agonists on Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF).
Cohort study of 107,252 peopleGLP-1 receptor agonists
Tuesday, October 7
Thursday, October 2
Nature Medicine
A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults
Meta-analysis of randomized trialsObesity
Monday, September 29
International Journal of Preventive Medicine
Economic Evaluation of Medications in Prevention and Treatment of Obesity: A Systematic Review
Systematic reviewObesity
Wednesday, July 30
American Family Physician
Top 20 Research Studies of 2024 for Primary Care Physicians
ReviewInterventions
Tuesday, April 22
Friday, March 7
JAMA Health Forum
Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults
Computational studyTirzepatide
Tuesday, August 20
Friday, October 13
Journal of the American Association of Nurse Practitioners
Current pharmacotherapies for obesity: A practical perspective
ReviewObesity